The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis
- 2 February 2010
- journal article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 29 (6) , 615-618
Abstract
To establish the diagnostic utility of the anti-cyclic-citrullinated peptide antibody (aCCP) test in Black South Africans with early rheumatoid arthritis (RA). A cross-sectional study comparing the rheumatoid factor (RF) and aCCP status in RA patients and a control group consisting of healthy subjects, and patients with systemic lupus erythematosus (SLE) and scleroderma. The sensitivity, specificity, positive (PPV) and negative predictive values of the aCCP test alone were 82.5%, 84.9%, 87.6% and 79% versus 81.7%, 90.7%, 92.5% and 78% for RF alone. The best specificity (95.3) and PPV (95.8%) was observed when both aCCP and RF tests were positive. Patients with erosive disease had a significantly higher mean RF titre compared with those with non-erosive disease (p = 0.007). There was a trend towards an association of smoking (OR = 4.1, 95% CI = 0.9–18.6) and functional disability (p = 0.07) with RF-positive status. No similar clinical associations were observed with aCCP. Almost a third of SLE patients were aCCP positive. Despite the best specificity and PPV observed when both the aCCP and RF tests were positive, our findings suggest that testing for aCCP is only cost-effective in the RF-negative patient in whom there is a strong clinical suspicion of RA.Keywords
This publication has 26 references indexed in Scilit:
- Are anti-citrulline autoantibodies better serum markers for rheumatoid arthritis than rheumatoid factor in Thai population?Rheumatology International, 2009
- The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosusLupus, 2009
- Osteoarticular tuberculosis in patients with systemic lupus erythematosusQJM: An International Journal of Medicine, 2009
- Anti?CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti?CCP2 antibodies in Egyptian patients with rheumatoid arthritisScandinavian Journal of Rheumatology, 2008
- Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid ArthritisAnnals of Internal Medicine, 2007
- Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature reviewAnnals of the Rheumatic Diseases, 2006
- Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosusClinical Rheumatology, 2006
- Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)Annals of the Rheumatic Diseases, 2004
- The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptideArthritis & Rheumatism, 2000
- Disease activity score.1992